​
​

Onconetix Ownership 2024 | Who Owns Onconetix Now?

OverviewForecastFinancialsChart

Institutional Ownership

15.46%

Insider Ownership

17.69%

Retail Ownership

66.85%

Institutional Holders

17.00

Onconetix Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----128-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----113,434-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----27,721-100.00%-Jun 30, 2024
UBS GROUP AG----3,599-100.00%-Jun 30, 2024

Onconetix's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----128-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----113,434-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----27,721-100.00%-Jun 30, 2024
UBS GROUP AG----3,599-100.00%-Jun 30, 2024

The largest Onconetix shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Onconetix (BWV), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----128-100.00%-Jun 30, 2024
UBS GROUP AG----3,599-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----27,721-100.00%-Jun 30, 2024
TWO SIGMA SECURITIES, LLC----113,434-100.00%-Jun 30, 2024

As of Jun 30 2024, Onconetix's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.13K stocks of BWV, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC----113,434-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----27,721-100.00%-Jun 30, 2024
UBS GROUP AG----3,599-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----128-100.00%-Jun 30, 2024

As of Jun 30 2024, Onconetix's biggest institutional seller is TWO SIGMA SECURITIES, LLC. The company sold -0.11M shares of BWV, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC----113,434-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----27,721-100.00%-Jun 30, 2024
UBS GROUP AG----3,599-100.00%-Jun 30, 2024
WELLS FARGO & COMPANY/MN----128-100.00%-Jun 30, 2024

Onconetix's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -0.11M shares, valued at -, as of undefined.

Onconetix Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%52,400--Feb 29, 2024
VANGUARD INDEX FUNDS0.00%73,513-73,513-50.00%Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%314--Jan 31, 2024
iSHARES TRUST0.00%16,680--Mar 31, 2024

Onconetix's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 52.40K shares, compromising 0.00% of its total assets.

Onconetix Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2417-19.05%
31 Dec, 232116.67%
30 Sep, 2318-5.26%
30 Jun, 231946.15%
31 Mar, 2313-27.78%
31 Dec, 221820.00%
30 Sep, 221587.50%
30 Jun, 228-38.46%
31 Mar, 2213-

As of 31 Mar 24, 17 institutions are holding Onconetix's shares, representing a decrease of -19.05% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 242,709,16911.86%
31 Dec, 232,421,823-32.08%
30 Sep, 233,565,69349.15%
30 Jun, 232,390,64747.56%
31 Mar, 231,620,167-16.32%
31 Dec, 221,936,159-17.87%
30 Sep, 222,357,568111.55%
30 Jun, 221,114,438143.56%
31 Mar, 22457,557-

Onconetix (BWV) has 2.71M shares outstanding as of 31 Mar 24, up 11.86% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2415.46%8.09%
31 Dec, 2313.82%3.34%
30 Sep, 2320.35%9.01%
30 Jun, 2315.03%14.49%
31 Mar, 2310.18%4.09%
31 Dec, 2215.78%5.84%
30 Sep, 2216.44%19.05%
30 Jun, 229.29%17.83%
31 Mar, 227.22%-

As of 31 Mar 24, Onconetix is held by 15.46% institutional shareholders, representing a 8.09% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 246-14.29%
31 Dec, 237-22.22%
30 Sep, 239-40.00%
30 Jun, 2315114.29%
31 Mar, 237-41.67%
31 Dec, 2212-7.69%
30 Sep, 221385.71%
30 Jun, 227-46.15%
31 Mar, 2213-

6 institutional shareholders have increased their position in BWV stock as of 31 Mar 24 compared to 7 in the previous quarter (a -14.29% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 242-50.00%
31 Dec, 23433.33%
30 Sep, 233-
30 Jun, 23350.00%
31 Mar, 232-50.00%
31 Dec, 224100.00%
30 Sep, 222-
30 Jun, 22--
31 Mar, 22--

2 institutional shareholders have reduced their position in BWV stock as of 31 Mar 24 compared to 4 in the previous quarter (a -50.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2417-19.05%2,709,16911.86%15.46%8.09%6-14.29%2-50.00%
31 Dec, 232116.67%2,421,823-32.08%13.82%3.34%7-22.22%433.33%
30 Sep, 2318-5.26%3,565,69349.15%20.35%9.01%9-40.00%3-
30 Jun, 231946.15%2,390,64747.56%15.03%14.49%15114.29%350.00%
31 Mar, 2313-27.78%1,620,167-16.32%10.18%4.09%7-41.67%2-50.00%
31 Dec, 221820.00%1,936,159-17.87%15.78%5.84%12-7.69%4100.00%
30 Sep, 221587.50%2,357,568111.55%16.44%19.05%1385.71%2-
30 Jun, 228-38.46%1,114,438143.56%9.29%17.83%7-46.15%--
31 Mar, 2213-457,557-7.22%-13---

Onconetix Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 03, 2024Schiess Ralphofficer Chief Science OfficerSell---269,749
Dec 28, 2023Bruhlmann Christianofficer Chief Strategy OfficerSell---236,029
Oct 10, 2023CAMPBELL NEIL Jdirector, officer Chief Executive OfficerSell532,326$0.43$229.17K-
Oct 10, 2023Harmon Bruceofficer Chief Financial OfficerSell177,442$0.43$76.39K-
Apr 12, 2023Cincinnati Cornerstone Investors BWV I, LLC10 percent owner-J-OtherSell1,200,000--1,161,201
Nov 21, 2022Cincinnati Cornerstone Investors BWV I, LLCdirector-J-OtherSell750,000--2,361,201
Aug 29, 2022Cincinnati Cornerstone Capital LLCdirector J-OtherSell500,000--3,111,201

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jan 03, 2024Schiess Ralphofficer Chief Science OfficerSell---269,749
Dec 28, 2023Bruhlmann Christianofficer Chief Strategy OfficerSell---236,029
Oct 10, 2023CAMPBELL NEIL Jdirector, officer Chief Executive OfficerSell532,326$0.43$229.17K-
Oct 10, 2023Harmon Bruceofficer Chief Financial OfficerSell177,442$0.43$76.39K-
Jun 01, 2023Jeremic Vukdirector-A-AwardBuy6,360--6,360
Jun 01, 2023Ramdeen Timothy R.director-A-AwardBuy6,360--6,360
Jun 01, 2023Tarsh Simondirector-A-AwardBuy6,360--6,360
Jun 01, 2023SAPIRSTEIN JAMESdirector-A-AwardBuy6,360--6,360
May 11, 2023Hernandez Josephdirector, 10 percent owner, officer CEOA-AwardBuy150,000--2,800,351
May 11, 2023Garfield Jonofficer Chief Financial OfficerA-AwardBuy100,000--100,000
May 11, 2023Henderson Erinofficer Chief Business OfficerA-AwardBuy150,000--174,752
Apr 12, 2023Cincinnati Cornerstone Investors BWV I, LLC10 percent owner-J-OtherSell1,200,000--1,161,201
Jan 30, 2023Ramdeen Timothy R.director-A-AwardBuy2,386--2,386
Jan 17, 2023Ramdeen Timothy R.--Buy----
Jan 17, 2023Ramdeen Timothy R.director Buy----
Nov 21, 2022Cincinnati Cornerstone Investors BWV I, LLCdirector-J-OtherSell750,000--2,361,201
Nov 09, 2022Jeremic Vukdirector-A-AwardBuy3,610--3,610
Nov 08, 2022Jeremic Vuk--Buy----
Nov 08, 2022Jeremic Vukdirector Buy----
Aug 29, 2022Cincinnati Cornerstone Capital LLCdirector J-OtherSell500,000--3,111,201

The last insider sell of Onconetix's stock was made by Schiess Ralph on Jan 03 2024, selling - shares at - per share (valued at -).

Onconetix Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202371700.00%
Q1 20231--
Q4 202211100.00%
Q3 20222540.00%
Q2 20227--
Q1 20221616.67%

7 total buy trades, and 1 total sell trades (buy/sell ratio of 7.00%) were made by Onconetix's insiders, as of Q2 2023.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2023---
Q1 2023---
Q4 2022---
Q3 2022-3-
Q2 2022---
Q1 2022---

As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Onconetix's stocks.

Onconetix Peer Ownership

TickerCompany
BDRXBiodexa Pharmaceuticals Plc
KPRXKiora Pharmaceuticals, Inc.
PXMDPaxMedica, Inc. Common Stock
REVBRevelation Biosciences, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
HILSTharimmune, Inc.
VRAXVirax Biolabs Group Limited
ALLRAllarity Therapeutics, Inc.
UNCYUnicycive Therapeutics, Inc.
CDIOCardio Diagnostics Holdings, Inc.
PALIPalisade Bio, Inc.

BWV Ownership FAQ

Onconetix is owned by institutional shareholders (15.46%), insiders (17.69%), and public (66.85%). The largest institutional shareholder of Onconetix is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Onconetix's major institutional shareholders are WELLS FARGO & COMPANY/MN, TWO SIGMA SECURITIES, LLC, VIRTU FINANCIAL LLC, and UBS GROUP AG. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2024, there are 17 institutional shareholders of Onconetix.

WELLS FARGO & COMPANY/MN owns 0 shares of Onconetix, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2024).

As of Jun 2024, TWO SIGMA SECURITIES, LLC holds 0 shares of Onconetix (BWV), compromising 0% of the company, valued at $0.

VIRTU FINANCIAL LLC is the third largest holder of Onconetix. The company owns 0 of the company's shares outstanding (worth $0).